Medicals Experts SUPPORT Side Effects Of ADHD Drugs

http://www.progressiveu.org/133039-a...hotic-behavior

"Jan Drew" wrote in message
. com...
http://www.progressiveu.org/133039-a...hotic-behavior

Did you read tha article?

http://today.reuters.com/News/newsAr...ADHD-DRUGS.xml

Panel backs new warnings on ADHD drugs
Thu Mar 23, 2006 10:25 AM ET



By Lisa Richwine

GAITHERSBURG, Maryland (Reuters) - U.S. advisers on Wednesday called for new
information about psychiatric and heart risks on the labels of attention
deficit drugs but stopped short of recommending the strongest possible
warning, saying they did not want to frighten patients or parents from
effective treatment.

The panel of pediatric experts reviewed reports of heart problems, psychotic
behavior, hallucinations and other psychiatric symptoms, in children who
took the medicines, which include Novartis AG's Ritalin and Shire Plc's
Adderall.

Patients, parents and doctors should know about the reports even though it
is unclear if the drugs contributed to the problems, panel members said.
They declined to recommend the "black box" warning -- the strongest for
prescription drugs -- that a different advisory panel narrowly endorsed last
month.

"You have overwhelming evidence of efficacy with two rare adverse events ...
A black box would scare many patients away from treatment," said panel
chairman Dr. Robert Nelson, a critical care specialist at The Children's
Hospital of Philadelphia.

The Food and Drug Administration will consider both panels' recommendations
before making a final labeling decision. Dr. Robert Temple, director of the
FDA's medical policy office, said officials likely would follow the
pediatric panel's recommendations for explaining risks to children but were
still mulling what to say about the dangers for adults.

Millions take prescription drugs to treat attention deficit hyperactivity
disorder (ADHD). The condition causes trouble with focus as well as
hyperactivity and impulsiveness. Symptoms can be so disabling that they
interfere with school or work and personal relationships.

Other ADHD drugs include Johnson & Johnson's Concerta, Novartis's Focalin,
GlaxoSmithKline Plc's Dexedrine and Eli Lilly and Co.'s Strattera.

Critics say the drugs are prescribed to people who do not need them.

The recent safety concerns have added to the controversy. FDA reviewers have
been working for months to analyze reports of sudden deaths, heart attacks
and strokes as well as psychiatric symptoms.

FDA staff said they were struck by reports of several children under age 10
who were taking the drugs and mistakenly thought they saw or felt bugs,
snakes and worms crawling on them. The hallucinations and other episodes
most often occurred in patients with no known risks factors for such
behavior, FDA staff said.

Panel members said they thought those problems should be highlighted on the
ADHD drug labels and described in a patient-friendly guide handed out with
prescriptions.

Cardiac problems also should be noted, panel members said, but stressed they
are most likely to be seen in children with a history of heart problems or
in adults.

"In the general run-of-the-mill kid, I think (ADHD drugs) are
well-tolerated. I don't think there's much risk at all if they don't have a
heart condition," said Dr. John Moore, a panel member and pediatric
cardiologist at Mattel Children's Hospital at UCLA in Los Angeles.

Last month, a different FDA panel of drug safety experts voted 8-7 to
recommend a black box warning about the potential for cardiac complications.

Adderall already carries a black box warning that misuse could lead to
cardiovascular problems, and Strattera has one cautioning that children and
teens who take it could have suicidal thoughts.

Makers of the ADHD drugs said they would work with the FDA to make sure
risks were communicated adequately.

"We are supportive of the suggestion that they made...of having some type of
heightened awareness around potential adverse events," Shire spokesman
Matthew Cabrey said.

"C A III A" wrote in message
...

"Jan Drew" wrote in message
. com...
http://www.progressiveu.org/133039-a...hotic-behavior

Did you read tha [sic] article?

I read the article I posted, Did you?

[snip]

"Jan Drew" wrote in message
. com...

"C A III A" wrote in message
...

"Jan Drew" wrote in message
. com...
http://www.progressiveu.org/133039-a...hotic-behavior

Did you read tha [sic] article?

I read the article I posted, Did you?

[snip]

The article you posted is another's opinion about Reuters original.
http://today.reuters.com/News/newsAr...ADHD-DRUGS.xml
Read it please. And follow your own links to the original source, not
someone' opinion. Here is what else was in the article:

-- "U.S. advisers [] stopped short of recommending the strongest possible
warning, saying they did not want to frighten patients or parents from
effective treatment."
-- "it is unclear if the drugs contributed to the problems"
-- "They declined to recommend the "black box" warning"
-- "You have overwhelming evidence of efficacy with two rare adverse events"
-- "Cardiac problems [] most likely to be seen in children with a history of
heart problems or in adults."
-- "...I don't think there's much risk at all if they don't have a heart
condition,"
-- "Makers of the ADHD drugs said they would work with the FDA to make sure
risks were communicated adequately"

C A III A wrote:
"Jan Drew" wrote in message
. com...
http://www.progressiveu.org/133039-a...hotic-behavior

Did you read tha article?

Jan wants the black box warnings, and nothing else will do. I base that
statement on reading millions of her posts about methylphenidate.


http://today.reuters.com/News/newsAr...ADHD-DRUGS.xml

Panel backs new warnings on ADHD drugs
Thu Mar 23, 2006 10:25 AM ET



By Lisa Richwine

GAITHERSBURG, Maryland (Reuters) - U.S. advisers on Wednesday called for new
information about psychiatric and heart risks on the labels of attention
deficit drugs but stopped short of recommending the strongest possible
warning, saying they did not want to frighten patients or parents from
effective treatment.

The panel of pediatric experts reviewed reports of heart problems, psychotic
behavior, hallucinations and other psychiatric symptoms, in children who
took the medicines, which include Novartis AG's Ritalin and Shire Plc's
Adderall.

Patients, parents and doctors should know about the reports even though it
is unclear if the drugs contributed to the problems, panel members said.
They declined to recommend the "black box" warning -- the strongest for
prescription drugs -- that a different advisory panel narrowly endorsed last
month.

"You have overwhelming evidence of efficacy with two rare adverse events ...
A black box would scare many patients away from treatment," said panel
chairman Dr. Robert Nelson, a critical care specialist at The Children's
Hospital of Philadelphia.

The Food and Drug Administration will consider both panels' recommendations
before making a final labeling decision. Dr. Robert Temple, director of the
FDA's medical policy office, said officials likely would follow the
pediatric panel's recommendations for explaining risks to children but were
still mulling what to say about the dangers for adults.

Millions take prescription drugs to treat attention deficit hyperactivity
disorder (ADHD). The condition causes trouble with focus as well as
hyperactivity and impulsiveness. Symptoms can be so disabling that they
interfere with school or work and personal relationships.

Other ADHD drugs include Johnson & Johnson's Concerta, Novartis's Focalin,
GlaxoSmithKline Plc's Dexedrine and Eli Lilly and Co.'s Strattera.

Critics say the drugs are prescribed to people who do not need them.

The recent safety concerns have added to the controversy. FDA reviewers have
been working for months to analyze reports of sudden deaths, heart attacks
and strokes as well as psychiatric symptoms.

FDA staff said they were struck by reports of several children under age 10
who were taking the drugs and mistakenly thought they saw or felt bugs,
snakes and worms crawling on them. The hallucinations and other episodes
most often occurred in patients with no known risks factors for such
behavior, FDA staff said.

Panel members said they thought those problems should be highlighted on the
ADHD drug labels and described in a patient-friendly guide handed out with
prescriptions.

Cardiac problems also should be noted, panel members said, but stressed they
are most likely to be seen in children with a history of heart problems or
in adults.

"In the general run-of-the-mill kid, I think (ADHD drugs) are
well-tolerated. I don't think there's much risk at all if they don't have a
heart condition," said Dr. John Moore, a panel member and pediatric
cardiologist at Mattel Children's Hospital at UCLA in Los Angeles.

Last month, a different FDA panel of drug safety experts voted 8-7 to
recommend a black box warning about the potential for cardiac complications.

Adderall already carries a black box warning that misuse could lead to
cardiovascular problems, and Strattera has one cautioning that children and
teens who take it could have suicidal thoughts.

Makers of the ADHD drugs said they would work with the FDA to make sure
risks were communicated adequately.

"We are supportive of the suggestion that they made...of having some type of
heightened awareness around potential adverse events," Shire spokesman
Matthew Cabrey said.

"Jan Drew" wrote in message
. com...
http://www.progressiveu.org/133039-a...hotic-behavior

The subject of this message is totally inaccurate.

No physician supports the side effects of ADHD medications.

And a blog? Come on. You should be able to your info from a better source
than a blog.

Jeff

"Jeff" wrote in message
link.net...

"Jan Drew" wrote in message
. com...
http://www.progressiveu.org/133039-a...hotic-behavior

The subject of this message is totally inaccurate.

No physician supports the side effects of ADHD medications.


Awesome!

And a blog? Come on. You should be able to your info from a better source
than a blog.

Jeff